Literature DB >> 3019778

In situ ductal carcinoma of the breast: implications of disease pattern and treatment.

I S Fentiman, N Fagg, R R Millis, J L Hayward.   

Abstract

Ninety-seven patients with in situ ductal carcinoma (DCIS) of the breast have been reviewed. The commonest presenting feature was a breast lump, and residual carcinoma was found in the mastectomy specimen in 63% of patients. Furthermore, 13 cases had evidence of infiltrating carcinoma when the mastectomy specimen was examined. Thus excision alone would have left residual in situ or infiltrating carcinoma in two-thirds of the cases. A wide excision, by removing local residual disease, would still have left multifocal disease in one-third of cases. Studies need to be conducted to determine whether conservative treatment of DCIS can yield results which are as good as those following total mastectomy.

Entities:  

Mesh:

Year:  1986        PMID: 3019778

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

1.  Ductal carcinoma in situ.

Authors:  I S Fentiman
Journal:  BMJ       Date:  1992-05-16

2.  Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision.

Authors:  H C Umpleby; A Herbert; G T Royle; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

3.  In situ breast carcinomas: a population-based study on frequency, growth pattern, and clinical aspects.

Authors:  M Blichert-Toft; H P Graversen; J Andersen; U Dyreborg; A Green
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

Review 4.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 5.  Non-invasive breast carcinoma.

Authors:  M C Posner; N Wolmark
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 6.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

Review 7.  Current management of ductal carcinoma in situ.

Authors:  A Barth; R J Brenner; A E Giuliano
Journal:  West J Med       Date:  1995-10

8.  Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Authors:  S T Brower; S Ahmed; P I Tartter; I Bleiweiss; J B Amberson
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

9.  The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.

Authors:  P A Holland; A Gandhi; W F Knox; M Wilson; A D Baildam; N J Bundred
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

10.  Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer.

Authors:  I D Campbell; J M Theaker; G T Royle; R Coddington; R Carpenter; A Herbert; I Moore; C Rubin; I Taylor; P B Guyer
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.